Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
12 Leser
Artikel bewerten:
(0)

Clinical Trial Regulatory Guideline Requirements Course: London, UK - November 24-25, 2015

DUBLIN, Sept. 2, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/n8xzhz/clinical_trial) has announced the addition of the "Clinical Trial Regulatory Guideline Requirements (London, UK - November 24-25, 2015)" conference to their offering.

Are you up to date with the regulatory requirements for clinical research in Europe? Do you understand the impact of the new EU Clinical Trials Regulation?

The EU Clinical Trials Regulation was finalised and published by the Official Journal of the EU in May 2014 and is due to come into force in 2016. This new regulation will replace the European Clinical Trials Directirs (2001/20/EC). This course will provide an essential understanding to help with compliance for clinical trials, particularly carried out in the EU.

This course will take you through the key regulatory and guideline requirements for clinical research in Europe, including the new Clinical Trial Regulation and existing Directive requirements. Also the key US requirements which impact on trials being carried out in Europe will also be briefly covered.

Benefits of Attending:

Attending this course will help ensure you are familiar with the regulations for running clinical trials and with the recent developments. The course will highlight the most important of these key requirements and changes and how these are likely to impact on trials now and in the future for pharmaceutical, biotechnology companies and study sites.

The course will include a number of group discussions and opportunities for you to discuss issues relevant to your own trials. To maximise the discussions you will be provided with copies of the key guidelines and the new EU Clinical Trial Regulation to review.

This course provides an overview and refresher of the current clinical trail regulatory requirements and an update on the New Clinical Trial Regulation.

For more information visit http://www.researchandmarkets.com/research/n8xzhz/clinical_trial

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.